HONG KONG — The discovery that a novel mechanism of CD4+ T helper (Th) cell differentiation is mediated by co-stimulation of glucocorticoid-induced tumor necrosis factor receptor- (TNFR)-related protein (GITR) explains the mechanism of action of GITR-mediated cancer immunotherapies and warrants clinical trials of GITR agonists, a Korean study has found.